We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-1.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$13.8M
(-11%)
Cap. Flow
-$2.56M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
44.3%
Holding
92
New
2
Increased
11
Reduced
51
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biodesix
BDSX
|
+$592K |
| 2 |
Moderna
MRNA
|
+$465K |
| 3 |
Personalis
PSNL
|
+$353K |
| 4 |
Magnite
MGNI
|
+$227K |
| 5 |
MDxHealth
MDXH
|
+$60.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FPAY
FlexShopper
FPAY
|
+$552K |
| 2 |
AKTS
Akoustis Technologies Inc
AKTS
|
+$464K |
| 3 |
Veracyte
VCYT
|
+$361K |
| 4 |
Rekor Systems
REKR
|
+$344K |
| 5 |
Medtronic
MDT
|
+$294K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.09% |
| 2 | Technology | 26.18% |
| 3 | Communication Services | 5.31% |
| 4 | Consumer Staples | 4.28% |
| 5 | Industrials | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Asure Software
ASUR
$253M
| $210K | 0.2% |
25,000
-5,000
| -17% | -$37.8K |
|
|
AKTS
77
DELISTED
Akoustis Technologies Inc
AKTS
| $154K | 0.15% |
1,173,001
-1,232,151
| -51% | -$464K |
|
78
Lantronix
LTRX
$252M
| $147K | 0.14% |
41,400
| – | – |
|
79
Journey Medical
DERM
$178M
| $124K | 0.12% |
22,000
| – | – |
|
80
NeuroOne Medical Technologies
NMTC
$14.8M
| $120K | 0.11% |
25,000
| – | – |
|
81
Accuray
ARAY
$32.2M
| $106K | 0.1% |
58,000
+9,500
| +20% | +$18.1K |
|
82
IRIDEX
IRIX
$14.4M
| $91K | 0.09% |
42,300
-3,000
| -7% | -$8.04K |
|
|
SCPH
83
DELISTED
scPharmaceuticals
SCPH
| $80K | 0.08% |
18,400
+7,800
| +74% | +$34.3K |
|
84
Shimmick
SHIM
$168M
| $80K | 0.08% |
51,900
| – | – |
|
85
CryoPort
CYRX
$781M
| $79K | 0.07% |
11,500
| – | – |
|
86
Dyadic International
DYAI
$38.6M
| $71K | 0.07% |
47,850
| – | – |
|
87
Senseonics Holdings Inc
SENS
$272M
| $34K | 0.03% |
4,200
-50
| -1% | -$445 |
|
|
AMRN
88
Amarin Corp
AMRN
$297M
| $10K | 0.01% |
725
-460
| -39% | -$7.91K |
|
|
89
Medtronic
MDT
$111B
| – | – |
-3,375
| Closed | -$294K |
|
|
90
Rekor Systems
REKR
$90M
| – | – |
-150,000
| Closed | -$344K |
|
91
Shopify
SHOP
$152B
| – | – |
-3,000
| Closed | -$232K |
|
|
RGF
92
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| – | – |
-10,958
| Closed | -$47K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Perkins Capital Management held 92 positions worth $106M, down 11% from $120M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Perkins Capital Management's Q2 2024 filing shows 2 new, 11 increased, 51 reduced and 4 closed positions. Its largest new stake was Biodesix: 20,739 shares worth $635K. The largest sale was FlexShopper, an estimated $552K.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q2 2024 buy was Biodesix: 20,739 shares worth $635K.
- Perkins Capital Management added most to Moderna in Q2 2024, an estimated $465K increase.
- Perkins Capital Management's biggest Q2 2024 reduction was FlexShopper, cutting an estimated $552K.
- Perkins Capital Management fully exited Rekor Systems in Q2 2024, selling an estimated $344K.
- Perkins Capital Management's ten largest holdings make up 44% of its $106M portfolio in Q2 2024.
- Perkins Capital Management opened 2 new positions and closed 4 in Q2 2024.
- Perkins Capital Management's portfolio value fell 11% quarter-over-quarter to $106M.
Based on Perkins Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.